Clinical Trial: Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.

U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07564895) titled 'Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.' on April 27.

Brief Summary: Relationships of B-cell Activating Factor Gene Polymorphisms With ulcerative colitis.

Study Start Date: March 01, 2018

Study Type: OBSERVATIONAL

Condition: Ulcerative Colitis (UC)

Recruitment Status: COMPLETED

Sponsor: Second Affiliated Hospital of Wenzhou Medical University

Disclaimer: Curated by HT Syndication....